Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Alteplase not yet proven for acute ischaemic stroke. Proceedings of the Royal College of Physicians of Edinburgh. Consensus Conference on Medical Management of Stroke, held in the College on 26–. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension. Perez-Stable EJ, Coates TJ, Baron RB, Biro BS, Hauck WW, McHenry KS, et al. Rockville, MD: National Bioethics Advisory Commission 1998. Volume I: Report and Recommendations of the National Bioethics Advisory Commission. Research Involving Persons with Mental Disorders That May Affect Decision-Making Capacity. Department of Health and Human Services, Agency for Health Care Policy and Research 1993. The rational and ethics of medication-free research in schizophrenia. Drug-free research in schizophrenia: an overview of the controversy. Navigating the ethics of medication-free research in schizophrenia.
Medication-free research with schizophrenic patients. Ethical dilemmas in clinical research with human subjects: an investigator's perspective.
Effects of medical interventions on suicidal behavior. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. Beasley CM, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH. Re: CCNP position paper on the use of placebos in psychiatry. Hazards of inference: the active control investigation. Placebo-controlled trials and active-control trials in the evaluation of new treatments. The continuing unethical use of placebo controls.
0 kommentar(er)
